These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24626262)

  • 21. Acute AT
    Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
    J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestine of dystrophic mice presents enhanced contractile resistance to stretching despite morphological impairment.
    Alves GA; Silva LR; Rosa EF; Aboulafia J; Freymüller-Haapalainen E; Souccar C; Nouailhetas VL
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G191-9. PubMed ID: 24284964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.
    Gehrig SM; van der Poel C; Sayer TA; Schertzer JD; Henstridge DC; Church JE; Lamon S; Russell AP; Davies KE; Febbraio MA; Lynch GS
    Nature; 2012 Apr; 484(7394):394-8. PubMed ID: 22495301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice.
    Whitehead NP; Pham C; Gervasio OL; Allen DG
    J Physiol; 2008 Apr; 586(7):2003-14. PubMed ID: 18258657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
    Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
    Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice.
    Ahmad N; Welch I; Grange R; Hadway J; Dhanvantari S; Hill D; Lee TY; Hoffman LM
    BMC Musculoskelet Disord; 2011 Jun; 12():127. PubMed ID: 21639930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB; Bostick B; Yue Y; Duan D
    Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.
    Albuquerque-Pontes GM; Casalechi HL; Tomazoni SS; Serra AJ; Ferreira CSB; Brito RBO; de Melo BL; Vanin AA; Monteiro KKDS; Dellê H; Frigo L; Marcos RL; de Carvalho PTC; Leal-Junior ECP
    Lasers Med Sci; 2018 May; 33(4):755-764. PubMed ID: 29209866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ghrelin improves muscle function in dystrophin-deficient mdx mice by inhibiting NLRP3 inflammasome activation.
    Chang L; Niu F; Chen J; Cao X; Liu Z; Bao X; Xu Y
    Life Sci; 2019 Sep; 232():116654. PubMed ID: 31306657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy.
    Yoon SH; Grynpas M; Mitchell J
    Bone; 2019 Apr; 121():232-242. PubMed ID: 30716510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology.
    Swiderski K; Martins KJ; Chee A; Trieu J; Naim T; Gehrig SM; Baum DM; Brenmoehl J; Chau L; Koopman R; Gregorevic P; Metzger F; Hoeflich A; Lynch GS
    Growth Horm IGF Res; 2016; 30-31():1-10. PubMed ID: 27544574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.
    Li H; Mittal A; Makonchuk DY; Bhatnagar S; Kumar A
    Hum Mol Genet; 2009 Jul; 18(14):2584-98. PubMed ID: 19401296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
    Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.